Hyunsun Jo
Founder & CEO
Pin Therapeutics
Hyunsun Jo received his B.S and Ph.D. degrees in Biological Sciences from Seoul National University and performed post-doctoral research at Gladstone Institute at UCSF.
He has spent the past 14 years as a biotech entrepreneur in the biotech industry, focusing on targeted protein degradation, where he has led new E3 ligase ligand discovery and conducted target validation across a wide range of proteins.




